Preclinical and clinical significance of VEGF deprivation in ovarian cancer through a specific active immunotherapy

HEBERSaVax (CIGB-247) - Center for Genetic Engineering and Biotechnology, Heber Biotec

https://oncologypro.esmo.org/meeting-resources/esmo-congress/preclinical-and-clinical-significance-of-vegf-deprivation-in-ovarian-cancer-through-a-specific-active-immunotherapy

Y. Morera1; M. Bequet-Romero2; F. Hernández-Bernal3; I. González-Moya2; K. Selman-Housein3; C. Canaan-Haden2; J. Sanchez-Ramirez2; Y. Martín-Bauta3; A. de la Torre-Santos4; M. Ayala3

Jul 27, 2023